Multimedia

Heart disease, high blood pressure, diabetes and cancers are usually considered diseases of the rich world, the result of too much food and too little exercise. But these serious diseases are already a huge problem in the developing world, accounting for about half of the burden of disease. Yet new research from the Center for Global Development has found that barely 3% of foreign aid and philanthropic spending for developing world health addresses these often overlooked diseases.

My guest this week is the lead author of that research, Rachel Nugent, CGD deputy director of global health. In a forthcoming working paper co-authored with Andrea Feigl – Scarce Donor Funding for Non-Communicable Diseases: Will it Contribute to a Health Crisis? – Rachel examines the impact of non-communicable diseases in the developing world and assesses the response of international donors. In the Wonkcast, we discuss her findings and recommendations for addressing this challenge.

The world is rapidly losing the ability to fight disease because of an invisible adversary: drug resistance. Resistance is inevitable but human actions are hastening it. Without a global effort to ensure lasting effectiveness of treatment, drug resistance is poised to get worse fast, raising costs, claiming more lives, and making future generations vulnerable to diseases that are easily cured today. After two years of study and analysis, CGD’s expert Drug Resistance Working Group urges four crucial steps to combat the problem in a pivotal new report, The Race Against Drug Resistance. On Tuesday, June 15, 2010 the Center for Global Development hosted the launch event of The Race Against Drug Resistance at the National Press Club.